跳至主要内容
临床试验/NCT04917926
NCT04917926已完成不适用

Effectiveness of Behavioural Economics-based Incentives on Glycaemic Control and Lifestyle in Adults With Newly Diagnosed Type 2 Diabetes: a Randomised Control Trial

The University of Hong Kong1 个研究点 分布在 1 个国家目标入组 122 人开始时间: 2021年6月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
122
试验地点
1
主要终点
Glycaemic control

研究概览

简要总结

A randomised control trial of adults with newly diagnosed type 2 diabetes to assess the effectiveness of behavioural economics-based incentives on healthy lifestyle behaviour, using a pragmatic trial approach.

详细描述

This is a randomised control trial of adults aged 30-70 with newly diagnosed type 2 diabetes within a year in Hong Kong to compare the effectiveness of financial incentives and combined financial and social incentives against a control group receiving standard care. We plan to recruit 261 participants and follow them for 9-months (6-month intervention period and a 3-month post-intervention follow-up period) to assess glycemic control and other health indicators. Participants will be randomly assigned to one of three groups (in ratio 1:1:1): arm A (financial incentives in addition to standard care), arm B (financial and social incentives in addition to standard care), and arm C (control arm receiving standard care). Financial incentives will be framed around loss aversion and the endowment effect. Social incentives will include peer competition, and social support. Financial and social incentives are to encourage increased physical activity and participants will use a pedometer to track activity. Participants are followed for an additional 3-months after the cessation of incentives to assess the sustainability of lifestyle changes.

This trial adopts a pragmatic study design based on the PRECIS-2 tool and RE-AIM frameworks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Care Provider, Outcomes Assessor)

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chinese adults aged 30-70 years
  • Capable of providing informed consent
  • Resident in Hong Kong
  • Able to communicate in English or Chinese
  • Diagnosed with type 2 diabetes within past year
  • 6.5% ≤ HbA1c ≤ 9.0%
  • Willing to take blood tests
  • Access to a phone to track physical activity and receive text messages
  • Physically mobile for duration of the trial

排除标准

  • Planned surgery in the next 6 months
  • Biological impairment or health condition affecting the ability to walk, such as blindness, physical immobility, and paralysis
  • Pregnant or breastfeeding
  • On insulin for diabetes control

结局指标

主要结局

Glycaemic control

时间窗: Baseline, 6-months, and 9-months

The change in HbA1c levels

次要结局

  • Walking performance(Weekly)
  • Changes in lipid profile(Baseline, 6-months, and 9-months)
  • Change in blood pressure(Baseline, 6-months, and 9-months)
  • Body weight control(Baseline, 6-months, and 9-months)
  • Glycaemic control(6-months and 9-months)
  • Glycaemic control (addition of medications)(6-months and 9-months)
  • Level of physical activity(Baseline, 6-months and 9-months)
  • Diabetes control(Baseline, 6-months, and 9-months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验